This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
302 |
4. Check minimum number of eventsNone |
302 |
5. Include endpointsNone |
302 |
6. Filter based on genotype QC (FinnGen only) |
269 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Liposarcoma
based on the number of shared cases.
Similar with more cases:
- Liposarcoma, including Hilmo
- Solid cancers
- Malignant neoplasm
- Malignant neoplasm
- Solid cancers, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 269 | 103 | 166 |
| Unadjusted period prevalence (%) | 0.06 | 0.04 | 0.08 |
| Median age at first event (years) | 62.70 | 59.70 | 64.56 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 281
- Matched controls
- 2810
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
46.6
119.4
73
21
WX302
NOMESCO Finland
Thoracal epidural anesthesy
40.0
112.8
72
24
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
+∞
84.8
77
*
130
Kela drug reimbursment
Malignant tumour
+∞
77.8
71
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
15.7
73.1
70
58
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
+∞
72.0
66
*
XX3DW
NOMESCO Finland
Time consuming IT work
15.0
63.9
62
52
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
62.9
58
*
H02AB02
ATC
dexamethasone; systemic
95.2
61.2
66
9
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
60.7
56
*
JN4AD
NOMESCO Finland
Body CT examination
10.1
56.9
75
98
JN4BD
NOMESCO Finland
Extensive body CT
12.2
56.7
63
65
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
20.4
52.6
42
24
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
50.6
47
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.2
48.0
89
170
B01AB10
ATC
tinzaparin; parenteral
8.2
47.5
74
117
A04AA02
ATC
granisetron; systemic, transdermal
+∞
46.1
43
*
WX402
NOMESCO Finland
General anaesthesia
5.7
44.7
120
323
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
17.4
44.2
38
25
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
43.9
41
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
+∞
42.8
40
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
10.7
39.8
47
52
A04AA01
ATC
ondansetron; systemic, rectal
15.8
38.9
35
25
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
15.4
36.3
33
24
TPH07
NOMESCO Finland
Cathetrisation of artery
5.8
34.2
76
169
B01AB05
ATC
enoxaparin; parenteral
4.4
34.0
144
538
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
132.7
33.5
35
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
132.7
33.5
35
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
33.3
118
385
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
124.1
31.4
33
*
WZC00
NOMESCO Finland
Treatment plan or consultation
4.2
30.7
131
485
L03AA13
ATC
pegfilgrastim; parenteral
336.7
30.4
30
*
Z51.5
ICD-10 Finland
Palliative care
8.7
30.1
41
54
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
29.7
28
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
29.7
28
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
323.7
29.4
29
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.3
29.1
197
994
ZXE10
NOMESCO Finland
More than one and less than three hours
3.9
28.0
148
627
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
27.5
26
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
27.5
26
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
298.1
27.2
27
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
8.8
27.0
36
46
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.1
27.0
39
55
WX306
NOMESCO Finland
Lumbar epidural anesthesy
8.1
26.5
38
53
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
26.5
25
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
26.5
25
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
26.5
25
*
L03AA02
ATC
filgrastim; parenteral
285.4
26.2
26
*
WF002
NOMESCO Finland
Radical radiotherapy
148.7
26.1
27
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
25.4
24
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
24.3
23
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.1
24.2
39
62
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
95.2
24.1
26
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
23.2
22
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
23.2
22
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.6
23.0
31
40
R4110
NOMESCO Finland
Physiotherapy
3.5
22.3
114
459
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
22.2
21
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
22.2
21
*
ZXE20
NOMESCO Finland
More than three and less than five hours
4.4
21.8
66
185
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
8.6
21.7
29
37
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
21.1
20
*
R4120
NOMESCO Finland
Occupational therapy
5.6
20.2
42
86
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
20.0
19
*
A04AD12
ATC
aprepitant; systemic
+∞
19.0
18
*
KAC00
NOMESCO Finland
Nephrectomy
+∞
19.0
18
*
WZC30
NOMESCO Finland
Teaching
3.9
18.6
65
201
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
18.2
48
120
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
29.0
18.1
24
9
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.3
18.0
32
56
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
17.9
17
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.0
17.9
59
175
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
191.6
17.7
18
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
191.6
17.7
18
*
XX2RW, ,
NOMESCO Finland
31.1
17.7
23
8
ZXD10
NOMESCO Finland
Scheduled procedure
2.9
17.3
136
683
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.1
17.2
24
32
N02AA05
ATC
oxycodone; systemic
3.5
17.0
71
247
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.8
16
*
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
16.8
16
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
95.9
16.8
18
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
18.2
16.4
25
15
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
15.8
15
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
15.8
15
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
15.8
15
*
WZC15, ,
NOMESCO Finland
169.0
15.6
16
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
19.1
15.4
23
13
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
12.9
15.4
27
23
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
84.6
14.7
16
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
14.7
14
*
116
Kela drug reimbursment
Prostate cancer
+∞
14.7
14
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
13.6
13
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
13.5
48
149
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
12.6
12
*
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
+∞
12.6
12
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.6
12
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
12.6
12
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
22.5
12.2
17
8
ZXA05
NOMESCO Finland
Left side
2.6
12.1
91
433
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
11.3
12.0
22
21
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
9.3
11.8
24
28
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
11.5
64
259
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
11.5
11
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
11.5
11
*
C49.62
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the trunk, unspecified localization liposarcoma
+∞
11.5
11
*
L02AE02
ATC
leuprorelin; implant, parenteral
36.7
11.4
14
*
S18
ICPC
Laceration/cut
2.4
11.1
159
1001
ZXE00
NOMESCO Finland
One hour or less
2.4
10.8
120
676
JFB43
NOMESCO Finland
Left hemicolectomy
114.1
10.5
11
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.5
10.5
21
41
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.5
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.5
10
*
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
+∞
10.5
10
*
A79
ICPC
Malignancy NOS
+∞
10.5
10
*
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
+∞
10.5
10
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
10.5
10
*
JAH00
NOMESCO Finland
Laparotomy
9.4
10.5
21
24
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
9.4
10.5
21
24
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
33.9
10.4
13
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
9.7
10.2
20
22
KFC00
NOMESCO Finland
Unilateral orchiectomy
20.9
9.9
14
7
JFB30
NOMESCO Finland
Right hemicolectomy
57.0
9.7
11
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.9
9.7
22
48
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.7
9.5
32
95
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
31.2
9.5
12
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
9.4
9
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
ZX120
NOMESCO Finland
Intravenous
4.0
9.4
28
76
JN4CD
NOMESCO Finland
Very extensive body CT
10.0
9.4
18
19
Z3226
NOMESCO Finland
Physiotherapist
2.6
9.4
63
280
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
38.0
9.1
11
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
38.0
9.1
11
*
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
38.0
9.1
11
*
TQW99
NOMESCO Finland
Other minor procedure on skin
4.7
9.0
21
47
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
51.6
8.7
10
*
WW500
NOMESCO Finland
Blood transfusion
8.7
8.7
18
22
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.8
8.6
27
76
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
8.6
73
360
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.3
8.5
18
23
B01AB04
ATC
dalteparin; parenteral
4.9
8.5
19
41
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
92.7
8.5
9
*
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
11.2
8.4
15
14
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.4
8
*
C48.82
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum liposarcoma
+∞
8.4
8
*
JLC10
NOMESCO Finland
Distal pancreatectomy
+∞
8.4
8
*
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
8.4
8
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
8.4
8
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
8.4
8
*
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
5.0
8.2
18
38
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
8.0
46
188
ZZR00
NOMESCO Finland
Flap of skin
46.3
7.8
9
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
8.4
7.7
16
20
N02BE01
ATC
paracetamol; systemic, rectal
3.4
7.6
259
2185
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
7.6
39
150
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
7.5
64
315
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
82.2
7.5
8
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
82.2
7.5
8
*
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
82.2
7.5
8
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
82.2
7.5
8
*
WX320
NOMESCO Finland
Spinalanesthesy
2.1
7.4
86
481
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
7.3
7
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
7.3
7
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
7.3
7
*
8850/3-C49.9
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues, NOS
+∞
7.3
7
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
7.3
7
*
JFB50
NOMESCO Finland
Other resection of colon
+∞
7.3
7
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
L02BB03
ATC
bicalutamide; oral
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.5
7.3
26
80
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.6
7.3
16
22
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
7.3
24
70
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.1
7.3
31
107
WX600
NOMESCO Finland
Single shot through catheter
20.7
7.2
10
5
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.6
7.1
17
27
HA1AA
NOMESCO Finland
X-ray mammography
6.6
7.1
17
27
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
7.9
7.0
15
20
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
14.2
6.9
11
8
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
14.2
6.9
11
8
ZXA00
NOMESCO Finland
Right side
2.1
6.9
86
492
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
17.2
6.8
10
6
D17.7
ICD-10 Finland
Benign lipomatous neoplasm of other sites
41.1
6.8
8
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.9
6.8
20
54
R4190
NOMESCO Finland
Nutritional therapy
6.7
6.7
16
25
JFB00
NOMESCO Finland
Partial resection of small intestine
23.2
6.7
9
*
R50.9
ICD-10 Finland
Fever, unspecified
2.5
6.7
47
212
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
12.7
6.6
11
9
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
10.4
6.6
12
12
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
71.4
6.5
7
*
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
71.4
6.5
7
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
71.4
6.5
7
*
TQB05
NOMESCO Finland
Puncture of skin of trunk
71.4
6.5
7
*
Z31.5
ICD-10 Finland
Genetic counselling
4.2
6.5
17
42
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.5
6.4
13
16
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
6.3
6
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
6.3
6
*
C48.12
ICD-10 Finland
Malignant tumor in specified localization in peritoneum liposarcoma
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
C49
ICD-10 Finland
Malignant neoplasm of other connective and soft tissue
+∞
6.3
6
*
JAA10
NOMESCO Finland
Excision of lesion of abdominal wall
+∞
6.3
6
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
27.3
6.3
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.4
6.2
47
219
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
59
123
5.81
28.15
3.9
1.7
3.30
2.60
ug/l
0.76
47
94
194
1032
3.84
25.03
4.5
2.4
—
—
estimate
—
0
0
118
553
2.95
17.00
3.8
2.1
—
—
—
0
0
196
1233
2.95
15.73
15.9
6.0
4.38
4.30
e9/l
0.19
174
1060
169
1015
2.67
14.32
8.5
3.8
34.54
35.89
g/l
2.37
161
960
81
351
2.84
12.99
8.7
6.4
105.30
104.65
mmol/l
0.53
81
351
74
307
2.91
12.86
10.4
7.1
0.20
0.99
mmol/l
1.09
66
252
74
309
2.89
12.69
10.7
7.2
5.20
5.05
kpa
1.03
74
299
74
309
2.89
12.69
10.7
7.2
14.64
12.10
kpa
3.53
74
299
179
1153
2.52
12.39
17.7
15.6
1.32
1.30
inr
0.15
147
941
134
758
2.47
12.34
3.6
2.9
23.08
152.77
e6/l
0.83
103
567
97
474
2.60
12.19
4.4
2.0
2.47
2.44
mmol/l
1.12
83
417
118
643
2.44
11.65
3.6
2.8
0.80
0.37
e6/l
0.51
87
454
128
756
2.27
10.17
7.1
2.0
2.36
2.35
mmol/l
0.13
116
663
232
1766
2.80
10.17
13.7
5.5
85.31
76.79
u/l
1.67
226
1659
160
1039
2.25
10.05
10.4
5.8
1.19
1.21
mmol/l
0.84
154
956
53
212
2.85
9.66
3.5
2.1
77.60
32.08
u/l
0.53
47
172
171
1159
2.21
9.43
10.9
6.2
1.19
1.21
mmol/l
1.70
150
1021
54
222
2.77
9.34
5.2
2.9
—
—
—
0
0
70
339
2.42
8.62
3.7
2.5
0.81
0.83
mmol/l
1.43
70
320
40
165
2.66
6.81
4.1
2.1
57.72
64.70
ml/min/173m2
0.66
18
70
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
64
3.64
6.71
3.0
2.5
0.32
0.36
iu/ml
0.29
12
31
37
151
2.67
6.43
1.4
1.3
—
—
—
0
0
48
223
2.39
6.37
4.6
2.1
225.85
233.62
u/l
0.13
48
209
261
2280
3.03
5.86
27.8
13.8
36.08
24.28
mg/l
5.39
243
1851
72
416
1.98
5.49
3.4
2.7
0.87
1.00
e6/l
0.22
39
212
164
1228
1.81
5.47
4.7
3.6
27.30
0.00
estimate
0.49
44
238
8
5
16.40
5.44
1.9
3.0
—
—
—
0
0
164
1240
1.77
5.18
4.7
3.6
0.00
0.00
estimate
-0.00
40
224
161
1212
1.77
5.15
4.7
3.6
0.00
0.00
estimate
-0.00
40
236
63
361
1.96
4.88
3.0
2.5
2.23
2.26
g/l
0.18
63
331
16
47
3.55
4.82
1.3
1.4
—
—
—
0
0
112
782
1.72
4.52
3.8
2.8
29.50
35.69
u/l
1.25
107
733
64
388
1.84
4.14
3.5
2.8
1.85
2.00
e6/l
0.08
30
185
62
375
1.84
4.03
3.8
1.8
30.77
29.11
s
1.44
62
365
124
927
1.60
3.65
4.8
3.5
0.00
0.00
estimate
-0.00
34
197
95
666
1.64
3.63
4.6
3.6
0.00
0.02
estimate
0.68
38
214
87
602
1.64
3.48
2.3
2.1
2.62
2.81
mg/l
0.34
76
523
14
47
3.08
3.46
1.7
1.3
—
—
—
0
0
50
297
1.83
3.43
1.9
1.8
—
—
—
0
0
15
54
2.88
3.31
1.5
1.3
—
—
—
0
0
6
7
8.72
3.28
2.0
2.0
17.67
10.29
%
—
6
7
11
29
3.90
3.22
1.5
1.2
—
—
—
0
0
13
44
3.05
3.18
1.6
1.1
—
—
—
0
0
249
2249
1.94
3.17
29.3
13.2
76.36
77.80
ml/min/173m2
0.52
237
2070
14
51
2.84
3.03
1.6
1.2
—
—
—
0
0
13
46
2.91
2.96
1.8
1.2
—
—
—
0
0
50
312
1.73
2.90
1.9
1.7
—
—
—
0
0
23
111
2.17
2.82
3.7
2.1
362.80
773.24
ug/l
0.51
23
105
16
66
2.51
2.76
1.1
1.3
—
—
—
0
0
15
60
2.58
2.75
2.0
3.6
1.60
1.47
index
—
10
32
8
19
4.30
2.70
2.0
1.3
—
—
—
0
0
8
19
4.30
2.70
2.3
1.3
—
—
—
0
0
13
49
2.73
2.66
3.1
2.1
1.67
1.59
mg/l
0.12
13
44
15
322
0.44
2.62
3.7
5.2
33.00
31.86
%
—
7
211
60
408
1.60
2.51
1.9
1.7
—
—
—
0
0
87
647
1.50
2.44
4.5
3.0
0.00
0.00
estimate
-0.00
33
182
12
46
2.68
2.39
1.7
1.2
—
—
—
0
0
11
39
2.89
2.37
1.7
1.2
—
—
—
0
0
30
173
1.82
2.28
12.1
6.7
24.42
24.17
mmol/l
0.22
30
166
70
506
1.51
2.23
4.4
4.1
54.76
311.96
ng/l
2.07
63
419
267
2524
2.16
2.16
42.8
21.0
4.39
4.54
e12/l
3.99
262
2452
9
31
2.96
2.09
7.4
5.4
11.79
11.61
mg/l
—
9
31
45
303
1.58
1.96
6.9
5.1
1.08
1.01
mmol/l
1.07
45
273
5
11
4.61
1.95
1.8
1.8
—
—
—
0
0
199
1771
1.42
1.94
3.9
4.2
13.38
11.86
mm/h
0.71
190
1649
8
28
2.91
1.87
2.3
1.3
—
—
—
0
0
261
2464
1.83
1.87
17.5
10.0
26.84
26.37
u/l
0.18
253
2385
22
123
1.86
1.86
1.3
1.5
—
—
—
0
0
5
12
4.22
1.83
2.6
1.3
—
—
—
0
0
8
29
2.81
1.80
1.4
1.6
3.60
4.46
u/ml
—
8
29
68
513
1.43
1.73
1.9
1.7
1.30
1.22
mg/l
0.12
57
415
5
13
3.89
1.72
2.0
1.3
—
—
—
0
0
5
13
3.89
1.72
2.6
1.2
—
—
—
0
0
8
32
2.54
1.61
4.9
2.8
12.63
11.52
mmol/l
—
8
32
83
657
1.37
1.59
3.1
2.4
386.40
362.90
umol/l
1.02
73
576
14
72
1.99
1.51
1.4
1.7
—
—
—
0
0
40
279
1.51
1.51
4.9
3.1
1.35
1.82
mmol/l
0.48
35
236
32
213
1.57
1.49
7.4
6.6
10.72
10.62
mmol/l
0.03
32
202
12
60
2.04
1.40
1.3
1.2
—
—
—
0
0
7
29
2.45
1.40
1.0
1.1
—
—
—
0
0
172
1535
1.31
1.40
3.1
3.2
64.76
49.07
u/l
0.55
164
1453
91
1087
0.76
1.35
1.9
1.9
1.56
1.33
mmol/l
1.33
68
903
6
24
2.53
1.31
1.7
1.7
1430.33
1462.67
mg
—
6
24
71
568
1.33
1.26
4.6
3.8
1.02
1.02
kg/l
0.31
50
364
6
25
2.43
1.25
1.0
1.1
—
1.33
—
0
9
5
21
2.41
1.09
1.4
1.2
—
—
—
0
0
16
97
1.69
1.09
1.9
2.1
35.63
39.86
u/l
0.34
16
85
19
122
1.60
1.05
13.4
4.5
1.73
1.59
%
0.40
19
117
11
60
1.87
1.04
1.7
1.6
—
—
—
0
0
5
22
2.29
1.04
1.4
1.2
—
—
—
0
0
5
22
2.29
1.04
1.6
1.2
119.30
170.99
pmol/l
—
5
22
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
5
23
2.19
0.98
1.4
1.2
—
—
—
0
0
105
912
1.24
0.96
4.6
4.0
22.94
24.43
%
0.40
53
440
14
85
1.68
0.96
1.6
3.5
—
—
—
0
0
99
856
1.24
0.94
3.2
3.1
1883.11
1360.92
ng/l
0.67
90
722
7
37
1.91
0.94
1.3
1.2
—
—
—
0
0
7
37
1.91
0.94
1.3
1.2
—
—
—
0
0
6
29
2.09
0.90
1.2
1.4
—
—
—
0
0
22
156
1.45
0.81
1.5
2.4
1.16
1.14
%
0.05
22
156
5
25
2.02
0.73
1.4
1.2
—
—
—
0
0
5
25
2.02
0.73
1.4
1.2
—
—
—
0
0
5
25
2.02
0.73
1.4
1.2
—
—
—
0
0
115
1034
1.19
0.71
3.3
2.9
194.76
133.13
ug/l
1.13
109
966
21
153
1.40
0.69
1.4
2.4
0.56
0.62
%
0.37
21
153
75
650
1.21
0.69
3.1
2.8
0.65
0.74
ug/l
0.76
57
428
5
30
1.68
0.61
1.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
2.0
—
26.33
—
0
6
6
37
1.63
0.56
1.2
1.3
—
—
—
0
0
37
305
1.25
0.55
1.5
1.5
—
—
—
0
0
124
1143
1.15
0.54
5.4
4.2
2.14
1.96
ug/l
0.25
112
1026
10
67
1.51
0.50
1.3
1.3
—
—
—
0
0
112
1031
1.14
0.49
3.5
3.8
40.90
40.95
ng/l
0.00
92
774
21
165
1.29
0.46
1.3
1.5
—
—
—
0
0
7
51
1.38
0.44
1.1
1.3
—
—
—
0
0
8
58
1.39
0.42
1.5
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
110
1025
1.12
0.38
2.5
2.5
74.40
77.21
nmol/l
0.51
105
912
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
9
67
1.35
0.38
1.1
1.1
—
—
—
0
0
222
2163
1.13
0.31
5.0
4.9
1.94
1.95
mu/l
0.08
202
1978
181
1746
1.10
0.31
4.2
3.9
14.91
14.92
pmol/l
0.02
163
1599
136
1297
1.09
0.29
2.9
2.7
—
—
—
0
0
88
824
1.10
0.28
3.7
2.2
179.60
318.78
u/l
0.82
88
774
33
293
1.14
0.25
11.6
7.1
—
—
—
0
0
228
2237
1.10
0.23
4.0
4.6
1.37
1.30
mmol/l
0.87
206
2053
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
9.35
—
0
10
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
39.73
—
0
12
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
46
499
0.91
0.21
1.2
1.3
0.63
1.81
u/ml
1.87
11
144
48
519
0.91
0.21
2.0
1.8
180000393.57
9281164.93
pmol/l
0.46
40
431
13
152
0.85
0.17
1.8
1.9
—
—
—
0
0
5
68
0.73
0.17
1.2
1.4
—
—
—
0
0
9
82
1.10
0.15
1.7
1.5
—
—
—
0
0
228
2310
0.93
0.14
5.3
5.4
6.24
6.05
mmol/l
0.89
207
2122
80
767
1.06
0.14
1.8
1.7
21.10
19.89
nmol/l
0.28
72
642
100
966
1.05
0.13
3.9
4.1
5.97
8.16
mg/mmol
0.41
66
608
14
157
0.89
0.11
1.7
1.9
3.50
3.52
mmol/l
—
9
123
46
438
1.06
0.10
1.3
1.3
42.84
30.86
iu/ml
0.22
17
131
12
135
0.88
0.10
1.9
1.8
—
—
—
0
0
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
6
54
1.11
0.09
1.0
1.8
209.33
266.98
mu/l
—
6
48
24
224
1.08
0.08
1.3
1.4
—
—
—
0
0
7
66
1.06
0.08
2.0
1.8
—
—
—
0
0
7
67
1.05
0.08
1.0
1.1
1.40
1.53
g/l
—
7
67
8
77
1.04
0.07
1.5
1.3
—
—
—
0
0
38
394
0.96
0.05
1.3
1.3
5.53
8.39
u/ml
0.31
14
135
116
1177
0.98
0.05
2.1
2.1
94.73
96.76
pmol/l
0.18
66
597
235
2364
0.96
0.05
4.8
5.5
4.52
4.51
mmol/l
0.04
217
2212
21
199
1.06
0.04
1.2
1.4
—
—
—
0
0
14
131
1.07
0.03
3.2
2.7
24.73
25.26
mmol/l
0.31
14
126
13
139
0.93
0.03
1.2
1.3
23.68
118.23
u/ml
—
6
57
16
151
1.06
0.03
1.1
1.3
—
33.79
—
0
15
42
431
0.97
0.03
1.8
1.8
1054.45
1164.19
nmol/l
0.25
32
337
10
94
1.07
0.01
2.3
1.9
35.50
41.97
nmol/l
—
10
89
229
2292
1.00
0.00
6.5
7.0
40.19
39.93
mmol/mol
0.17
213
2161
240
2399
1.00
0.00
5.6
6.3
2.63
2.63
mmol/l
0.02
221
2235
235
2349
1.00
0.00
4.7
5.4
1.36
1.43
mmol/l
2.22
214
2182
10
104
0.96
0.00
1.1
1.0
—
—
—
0
0
10
104
0.96
0.00
1.2
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
48.35
—
0
6
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
-0.00
1.1
1.1
0.98
0.89
g/l
—
7
69
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
2.2
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
1884.29
—
0
7
9
89
1.01
-0.00
1.7
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIPOSARCOMA – Liposarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).